Here are the 5 biotech stocks that can 10x:
1. $HIMS - $6.86B MC and $2.58B TTM revenue (+28%), 3M subscribers, GLP-1s + international expansion
2. $RXRX - $2.01B MC and AI drug discovery. Roche/Genentech + NVIDIA partnerships, internal pipeline
3. $MRNA - $79.4B MC and $2.23B TTM revenue. Massive cash pile, vaccines + oncology + rare diseases
4. $TEM - $15.3B MC and $1.43B TTM revenue (+50%). 2026 guide of $1.6B, oncology diagnostics + AI
5. $CRSP - $5.24B MC and CASGEVY revenue accelerating. First approved CRISPR therapy, $2.36B cash
Thank me later.
@sorianmare My experience in retail is probably the biggest reason I can never be bullish $PYPL. Because it's such a POS (and I don't mean point of sale😆
@sorianmare As someone who worked in retail many years ago I fully agree.
The ease at which we were able to process returns made by customers using Apple Pay was night and day.
Especially compared to the glitchiness of PayPal returns
@BowTiedLobster@RassaSamimi@gbrew24 They can't. Export tarrifs are illegal.
Article I, Section 9, Clause 5 of the US Constitution
"No Tax or Duty shall be laid on Articles exported from any State".
Northeastern states would be FUBAR.
Pipelines are already at max capacity.
And the Jones Act (essentially) prevents shipping US diesel between US ports.
Probably end up with worse diesel prices than the EU.
TRUMP SAYS HE IS CONSIDERING A DIESEL EXPORT BAN 'VERY SERIOUSLY' AND THAT THE U.S. MAY IMPLEMENT IT, THOUGH IT COULD CAUSE A SMALL RISE IN GASOLINE PRICES.
@DoubleWideCap@INArteCarloDoss You'd think at least one person in his cabinet would mention the Jones Act and the implications this ban would have for northeasterners